Thomson Medical’s FY2024 earnings plunges 57.8% to $15.4m

Earnings per share stood at $0.058.

Thomson Medical Group (TMG) reported a 57.8% year-on-year (YoY) decline in earnings for FY2024 to $15.4m from $36.5m a year ago.

Net profit for the period also slumped 52.5% YoY to $19.5m from $41.1m in FY2023.

Revenue for the period slightly dropped 1.3% YoY to $351.2m.

The group’s EBITDA also slipped 0.9% YoY to $102.4m from $103.3m a year ago, impacted by long-term operations investments, lower income from COVID-19-related projects, and costs and foreign exchange losses from the acquisition of FV Hospital (FEMVN).

Earnings per share stood at $0.058 from $0.138 in the previous period.

Follow the link for more news on

Thomson Medical

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia